查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466219

人类微生物组市场：按疾病、技术、产品、治疗领域、应用分类 - 全球预测 2024-2030

Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年人类微生物组市场规模预计为15.8亿美元，预计2024年将达到19.6亿美元，2030年将达到71.1亿美元，复合年增长率为23.90%。

人类微生物组是存在于人体内的微生物基因组的集合。这包括细菌、古细菌、病毒和真核微生物。人体含有数兆个微生物细胞，影响身体功能和健康。帮助消化食物，抵抗病原体，并发展免疫系统。同时，慢性病盛行率的上升以及将微生物组与各种健康状况联繫起来的研究需求进一步推动了对基于微生物组的诊断和治疗的需求。营养领域对微生物组的需求不断增长，推动了对人类微生物组支持和影响整体健康和免疫功能的需求。然而，与活生物治疗产品核准相关的监管障碍以及理解和操纵微生物组的复杂性给主要参与者带来了重大挑战。本公司继续专注于研发 (R&D) 活动以及具有成本效益且易于使用的定序技术，以优化业务成长。此外，新治疗剂开发的重大进展和投资增加正在为全球地区运营的主要企业创造重大机会。人工智慧 (AI) 和高级机器学习 (ML) 等开发的关键技术正在与微生物组研究相结合，以更好地了解复杂的微生物相互作用并开发新的治疗解决方案。

主要市场统计
基准年[2023] 15.8亿美元
预测年份 [2024] 19.6亿美元
预测年份 [2030] 71.1亿美元
复合年增长率（%） 23.90%

技术 16s rRNA定序和体学技术的最新进展使研究人体内的分子因素和过程成为可能

16s 核醣体 RNA定序是一种广泛使用的技术，用于识别和比较样本中的细菌。它重点关注 16S rRNA 基因，该基因是原核核醣体 30S 小次单元的组成部分，在不同物种的细菌和古细菌中高度保守。这项技术可以帮助研究人员对细菌进行分类并确定其谱系，从而深入了解微生物组的组成。另一方面，细胞培养技术涉及在受控条件下（通常在自然环境之外）培养细胞。在微生物组研究中，细胞培养技术使我们能够分离和维持微生物以进行研究。包括次世代定序仪(NGS) 在内的高通量技术彻底改变了微生物群落研究的速度和规模。这些技术可以同时对数百万个 DNA 分子进行定序，从而全面了解微生物组的多样性和功能。此外，元基因组分析可以分析从环境样本中获得的遗传物质，从而消除了研究人员在实验室培养生物体的需要。这项技术对于研究人类微生物组很有用，因为它可以对所有存在的微生物的遗传物质进行独立于培养的检查，甚至是那些不易在试管内生长的微生物。此外，基因组学、转录组学、蛋白质组学和代谢体学等体学技术提供了对生物系统的整体情况和高解析度见解。在微生物组研究中，这些技术询问各种分子因素和过程，包括基因组 RNA 转录物、蛋白质体学和微生物群落的代谢物。

应用扩大人类微生物组在各种健康状况的医疗保健诊断和治疗中的应用

人类微生物组是存在于人体内部和表面的微生物基因组的集合，其在诊断方面的潜力是一个越来越受关注的领域。次世代定序仪和生物资讯学的进步使研究人员能够将特定的微生物组成和活性与各种健康状况联繫起来。在诊断领域，分析人类微生物组有助于识别发炎性肠道疾病、糖尿病和某些癌症等疾病的生物标记。在治疗领域，人类微生物群透过基于微生物群的疗法提供了个人化医疗的潜力。粪便微生物移植（FMT）用于透过恢復健康的微生物平衡来治疗困难梭状芽孢桿菌传染病。

区域洞察

在美洲，在先进的微生物组研发和商业化的推动下，美国和加拿大的人类微生物组经历了显着增长，许多公司积极致力于开发基于微生物组的治疗方法和诊断方法。该地区的人类微生物组景观正在稳步发展，研究重点是了解微生物组对人类健康和疾病的影响。同时，欧洲国家政府对微生物组研究展现了强有力的支持，并建立了许多倡议和研究联盟。欧洲的法律规范正在不断发展，以支持微生物组资料和产品的安全和道德的使用。中东和非洲地区是人类微生物组产品不断增长的市场，这主要是由于与文明病的增加和医疗保健支出的增加。同时，由于人们越来越认识到微生物平衡对整体健康的重要性、医疗保健成本不断上升以及微生物基因组学的进步，亚太地区人类微生物组市场正在显着增长。该地区益生菌、益生元和合合益素的研究和开发正在不断发展，特别是为了解决胃肠道疾病和慢性病等当地健康问题。

FPNV定位矩阵

FPNV定位矩阵对于评估人类微生物组市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对人类微生物组市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1. 人类微生物组市场的市场规模与预测是多少？

2.在人类微生物组市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.人类微生物组市场的技术趋势和法规结构是什么？

4.人类微生物组市场主要厂商的市场占有率是多少？

5. 进入人类微生物组市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 专注于开发人类微生物组疗法
      • 用于药物发现、早期疾病检测和诊断的人类微生物组
      • 益生菌和婴儿营养中微生物组的需求增加
    • 抑制因素
      • 缺乏微生物组治疗的专业知识和安全问题
    • 机会
      • 增加合作和研究投资以创造成长机会
      • 新治疗药物的开发
    • 任务
      • 了解细菌种类数量的限制以及基于人类微生物组的药物的不确定性
  • 市场区隔分析
    • 技术：16s rRNA定序和体学技术的最新进展，用于研究人体分子因素和过程
    • 应用：人类微生物组在医疗保健诊断和治疗中的应用越来越多，以解决各种健康状况。
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化
    • 智慧财产权情况

第六章人类微生物组市场：依疾病分类

  • 急性腹泻
  • 自体免疫疾病
  • 癌症
  • 糖尿病
  • 精神障碍
  • 肥胖

第七章人类微生物组市场：依技术分类

  • 16s rRNA定序
  • 细胞培养技术
  • 计算工具
  • 高通量技术
  • 元基因组定序
  • 体学技术

第八章人类微生物组市场：副产品

  • 诊断设备
  • 药物
  • 食品
  • 益生元和益生菌

第 9 章按治疗领域分類的人类微生物组市场

  • 胃肠道疾病
  • 代谢紊乱
  • 皮肤病
  • 女性健康

第十章人类微生物组市场：依应用分类

  • 诊断
  • 治疗药物

第十一章美洲人类微生物组市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区人类微生物组市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲人类微生物组市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 临床微生物组学宣布与 CosmosID 合併
    • 雀巢与 APC Microbiome 合作开发健康与福祉产品
    • 华盛顿大学医学院建立新的微生物体研究中心

第15章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-430D42AA0FCD

[198 Pages Report] The Human Microbiome Market size was estimated at USD 1.58 billion in 2023 and expected to reach USD 1.96 billion in 2024, at a CAGR 23.90% to reach USD 7.11 billion by 2030.

The human microbiome is the collective genomes of the microorganisms that reside on and inside the human body. These include bacteria, archaea, viruses, and eukaryotic microbes. The human body hosts trillions of these microbial cells, which can influence bodily functions and health. It assists in the digestion of food, protection against pathogens, and the development of the immune system. Meanwhile, the rise in chronic disease prevalence and a growing need for research linking the microbiome to various health conditions further stokes demand for microbiome-based diagnostics and therapeutics. The growing need for a microbiome in nutrition propels the demand for a human microbiome to support and influence overall wellness and immune function. However, the regulatory hurdles associated with approving live biotherapeutic products and complexities in comprehending and manipulating the microbiome present a significant challenge for the key players. Companies are continuously focusing on research and development (R&D) activities and cost-effective and accessible sequencing technologies to optimize their business growth. Moreover, the advancements in developing novel human microbiome therapeutics and rising investments present a significant opportunity for the key companies operating in the global space. Emerging technologies such as artificial intelligence (AI) and advanced machine learning (ML) are integrated with microbiome research to understand complex microbial interactions better and develop novel therapeutic solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 1.58 billion
Estimated Year [2024] USD 1.96 billion
Forecast Year [2030] USD 7.11 billion
CAGR (%) 23.90%

Technology: Recent advancements in 16s rRNA sequencing and omics technology to investigate molecular factors and processes in human body

16s ribosomal RNA sequencing is a widely used method for identifying and comparing bacteria within a sample. It focuses on the 16S rRNA gene, a component of the 30S small subunit of prokaryotic ribosomes, which is highly conserved within different species of bacteria and archaea. This technique helps researchers classify and determine the phylogeny of bacteria, providing insights into the microbiome's composition. On the other hand, cell culture technology involves growing cells under controlled conditions, typically outside their natural environment. In microbiome research, cell culture technology allows scientists to isolate and maintain microorganisms for study. High-throughput technologies, including next-generation sequencing (NGS), have revolutionized the speed and scale at which microbial communities can be studied. These methods allow for the simultaneous sequencing of millions of DNA molecules, offering a comprehensive view of the microbiome's diversity and function. Moreover, metagenomic sequencing analyzes the genetic material obtained from environmental samples, helping researchers bypass the need to cultivate organisms in the lab. This technology helps study the human microbiome by allowing for a culture-independent examination of the genetic material of all microorganisms present, including those not easily cultured in vitro. Furthermore, omics technologies, such as genomics, transcriptomics, proteomics, and metabolomics, provide holistic views and high-resolution insights into biological systems. In microbiome research, these technologies investigate various molecular factors and processes, such as the genomics RNA transcripts, proteomics, and metabolites of microbial communities.

Application: The increasing adoption of the human microbiome in healthcare diagnostics and therapeutics to cater to various health conditions

The human microbiome, comprised of the collective genome of microorganisms residing in and on the human body, has become an area of increasing interest for its potential in diagnostics. Advancements in next-generation sequencing and bioinformatics have allowed researchers to correlate specific microbial compositions and activities with various health conditions. For diagnostics, analysis of the human microbiome facilitates the identification of biomarkers for diseases such as inflammatory bowel disease, diabetes, and certain types of cancer. In the therapeutic domain, the human microbiome offers the potential for personalized medicine through microbiota-based treatments. Fecal microbiota transplantation (FMT) is used to treat clostridium difficile infections by restoring a healthy microbial balance.

Regional Insights

In the Americas, the United States and Canada witnessed significant growth in human microbiome driven by the research and commercialization of advanced microbiome, with numerous companies actively engaged in developing microbiome-based therapies and diagnostics. The human microbiome landscape in this region is steadily growing, focusing on research aimed at understanding the impact of the microbiome on human health and disease. On the other hand, European countries exhibit strong government support for microbiome research with numerous initiatives and research consortia in place. The regulatory framework in Europe is evolving to support the safe and ethical use of microbiome data and products. The Middle East and Africa region represents a growing market for human microbiome products, primarily driven by an increasing burden of lifestyle diseases and growing healthcare expenditure. At the same time, the human microbiome landscape in the Asia-Pacific region is experiencing significant growth, driven by increasing awareness of the importance of microbial balance to overall health, rising healthcare expenditures, and advancements in microbial genomics. Research and development in probiotics, prebiotics, and symbiotics are growing in this region, particularly in addressing regional health issues such as gastrointestinal disorders and chronic diseases.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Human Microbiome Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Human Microbiome Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Human Microbiome Market, highlighting leading vendors and their innovative profiles. These include AOBiome, LLC, Astarte Medical Partners, Inc, Axial Therapeutics, Inc., Azitra, BiomeSense, Inc., BiomX Ltd., DuPont de Nemours, Inc., Enterome Bioscience, Evelo Biosciences, Inc., Exeliom Biosciences SAS, Ferring B.V., Finch Therapeutics Group, Inc., Illumina, Inc., Intralytix, Inc., Invivo Healthcare, Locus Biosciences, Inc., Merck KGaA, Metabiomics Corporation, Osel Inc., Rebiotix Inc., Second Genome, Inc., Seres Therapeutics, Inc., Synlogic, Inc., Theriva Biologics, Inc., Vedanta Biosciences, Inc., Viome Life Sciences, Inc., and Yakult Honsha Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Human Microbiome Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease
    • Acute Diarrhea
    • Autoimmune Disorders
    • Cancer
    • Diabetes
    • Mental Disorders
    • Obesity
  • Technology
    • 16s rRNA Sequencing
    • Cell Culture Technology
    • Computational Tools
    • High-Throughput Technology
    • Metagenomic Sequencing
    • Omics Technology
  • Product
    • Diagnostic Devices
    • Drugs
    • Foods
    • Prebiotic & Probiotics
  • Therapeutic Area
    • Gastrointestinal Disorders
    • Metabolic Disorders
    • Skin Disorders
    • Women's Health
  • Application
    • Diagnostics
    • Therapeutics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Human Microbiome Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Human Microbiome Market?

3. What are the technology trends and regulatory frameworks in the Human Microbiome Market?

4. What is the market share of the leading vendors in the Human Microbiome Market?

5. Which modes and strategic moves are suitable for entering the Human Microbiome Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased Focus on Development of Human Microbiome Therapy
      • 5.1.1.2. Human Microbiome for Drug Discovery, Early Disease Detection, and Diagnosis
      • 5.1.1.3. Increasing Demand for Microbiome in Probiotics and Infant Nutrition
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Expertise and Safety Issue related to Microbiome Therapeutics
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing Collaborations and Research Investments to Create Growth Opportunities
      • 5.1.3.2. Development of Novel Human Microbiome Therapeutic Products
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations in Understanding Number of Bacterial Species and Uncertainty of Human Microbiome-Based Drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Recent advancements in 16s rRNA sequencing and omics technology to investigate molecular factors and processes in human body
    • 5.2.2. Application: The increasing adoption of the human microbiome in healthcare diagnostics and therapeutics to cater to various health conditions
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization
    • 5.9.1. Intellectual Property Landscape

6. Human Microbiome Market, by Disease

  • 6.1. Introduction
  • 6.2. Acute Diarrhea
  • 6.3. Autoimmune Disorders
  • 6.4. Cancer
  • 6.5. Diabetes
  • 6.6. Mental Disorders
  • 6.7. Obesity

7. Human Microbiome Market, by Technology

  • 7.1. Introduction
  • 7.2. 16s rRNA Sequencing
  • 7.3. Cell Culture Technology
  • 7.4. Computational Tools
  • 7.5. High-Throughput Technology
  • 7.6. Metagenomic Sequencing
  • 7.7. Omics Technology

8. Human Microbiome Market, by Product

  • 8.1. Introduction
  • 8.2. Diagnostic Devices
  • 8.3. Drugs
  • 8.4. Foods
  • 8.5. Prebiotic & Probiotics

9. Human Microbiome Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Gastrointestinal Disorders
  • 9.3. Metabolic Disorders
  • 9.4. Skin Disorders
  • 9.5. Women's Health

10. Human Microbiome Market, by Application

  • 10.1. Introduction
  • 10.2. Diagnostics
  • 10.3. Therapeutics

11. Americas Human Microbiome Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Human Microbiome Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Human Microbiome Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Clinical Microbiomics Announces Merger with CosmosID
    • 14.3.2. Nestle Partners APC Microbiome on Health and Wellbeing Products
    • 14.3.3. UW Medicine Launches a New Center to Study Microbiomes

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. HUMAN MICROBIOME MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN MICROBIOME MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HUMAN MICROBIOME MARKET DYNAMICS
  • FIGURE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. HUMAN MICROBIOME MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. HUMAN MICROBIOME MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN MICROBIOME MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN'S HEALTH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN'S HEALTH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 148. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 152. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 158. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 159. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 160. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 161. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 168. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 169. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 174. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 175. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 178. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 179. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 184. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 185. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 188. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 189. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 190. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 191. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 194. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 195. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 198. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 204. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 208. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 209. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 214. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 215. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 218. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 220. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 224. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 228. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 229. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 232. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 233. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 234. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 235. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 238. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 239. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 244. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 245. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 248. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 249. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 250. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 251. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 254. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 255. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 269. DENMARK HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 270. DENMARK HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 271. DENMARK HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. DENMARK HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. DENMARK HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. DENMARK HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. DENMARK HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 276. DENMARK HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 277. DENMARK HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. DENMARK HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. EGYPT HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 280. EGYPT HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 281. EGYPT HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 282. EGYPT HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 283. EGYPT HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. EGYPT HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. EGYPT HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 286. EGYPT HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 287. EGYPT HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. EGYPT HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. FINLAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 290. FINLAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 291. FINLAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 292. FINLAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 293. FINLAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. FINLAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. FINLAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 296. FINLAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 297. FINLAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. FINLAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 300. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 301. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 302. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 303. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 306. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 307. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 310. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 311. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 312. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 313. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 314. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 315. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 316. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 317. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 320. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 321. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 322. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 323. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 325. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 326. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 327. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 330. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 331. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 332. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 333. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 336. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 337. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 340. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 341. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 342. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 343. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 346. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 347. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 349. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 350. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 351. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 352. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 353. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 354. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 355. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 356. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 357. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. NORWAY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 360. NORWAY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 361. NORWAY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 362. NORWAY HUMAN MICROBIOME MARKET SIZE, BY TEC